Stock screener

PCRX

Conviction 69HealthcareScan · Thu, Sep 24, 2026
Bullish engulfing

Pacira BioSciences, Inc. (PCRX) closed at $25.58 (+3.86%) on Sep 24, 2026. Its latest daily candle is a bullish engulfing. Price is above its 50-day and above its 200-day moving average. RSI(14) 54, RS Rating 49, -7.4% from its 52-week high, +4.6% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

PCRX$25.58+3.86%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 541.67K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Pacira BioSciences, Inc.PHARMACEUTICAL PREPARATIONSwww.pacira.com ↗
Price25.58
Change+3.86%
Gap-0.20%
Rel volume1.10×
Avg volume539.98K
Avg $ vol13.71M
SMA 2025.38
SMA 5025.31
SMA 20023.91
Price vs 50+1.07%
Price vs 200+7.00%
MA stackbullish
50/200 cross—
Supertrenddown · 26.73
RSI (14)54
MACD hist-0.04
MACD crossbear · 9d
Stoch %K / %D64 / 42
ADX (14)18
+DI / −DI18 / 19
RSI divergence—
MACD divergence—
ATR %3.20%
ADR %2.95%
52w high27.62
52w low19.16
From 52w high-7.39%
Above 52w low+33.51%
New 52w highNo
SqueezeOff
Bollinger width12.50%
%B0.56
Donchian pos59.20%
Donchian high26.91
Donchian low23.65
AVWAP (52w high)25.06
vs AVWAP high+2.07%
AVWAP (52w low)23.54
vs AVWAP low+8.66%
OBV trendFlat
Chaikin MF (20)0.07
Today vs 20d1.10×
Avg vol (14d)541.67K
Avg vol (20d)539.98K
Avg $ vol (20d)13.71M
Market cap1.02B
RS Rating49 / 99
RS 3m (vs SPY)+0.47%
RS 6m (vs SPY)-7.92%
RS line new highNo
Trend template8/8
Technical rank71.4
1 week+4.49%
1 month+0.20%
3 months+4.97%
6 months+8.90%
1 year-2.40%
YTD+4.58%
P/E144.96
P/B1.52
P/S1.40
P/FCF7.46
EPS0.1600
Div yield—
ROE1.05%
ROA0.57%
Debt/Eq0.54
Current5.04
EV/EBITDA10.68
Gross margin—
Net margin0.97%
Rev growth3.63%
EPS growth107.07%
Price target29.14
Target upside13.92%
Analyst ratingBuy
Institutional122.09%
Ent. value1.18B
Revenue192.4M
Net income4.65M
Gross profit—
Free cash flow136.66M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees829
ListedThu, Feb 3, 2011
Free float37.93M
Float %93.7%
Short interest7.33M
Days to cover16.9d
Short volume75.0%
Squeeze score85 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.44 vs $0.27
Last surprise+63.0% beat
Setup gradeB
Conviction69 / 100
Pattern quality—
Tech rank71.4 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PCRX

All disclosures →
No recent disclosed trades by Congress in PCRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PCRX · open-market 3 sells

InsiderSideShares
SLONIN JONATHAN
Chief Medical Officer · Common Stock · 2026-08-17
Sell3.04K
BIGAL MARCELO
Director · Stock Option (Right to Buy) · 2026-06-10
Grant10.89K
BIGAL MARCELO
Director · Common Stock · 2026-06-10
Grant6.41K
WILLIAMS KRISTEN
Chief Administrative Officer · Common Stock · 2026-06-04
Sell10.26K
SLONIN JONATHAN
Chief Medical Officer · Common Stock · 2026-06-03
Tax4.73K
WILLIAMS KRISTEN
Chief Administrative Officer · Common Stock · 2026-06-03
Tax8.53K
RIKER LAUREN
Senior Vice President, Finance · Common Stock · 2026-06-03
Tax3.19K
Cross Shawn
Chief Financial Officer · Common Stock · 2026-04-23
Exercise12.94K
Cross Shawn
Chief Financial Officer · Stock Option (Right to Buy) · 2026-04-23
Exercise12.94K
Cross Shawn
Chief Financial Officer · Common Stock · 2026-04-23
Sell12.94K

SEC filings

EDGAR filings in PCRX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.